DaVita Clinical Research Welcomes New Medical Director

Comments
Print

MINNEAPOLIS—DaVita Clinical Research (DCR) announced today that  Jolene K. Berg, MD, has been appointed medical director of the DaVita Clinical Research Phase I center in Minneapolis.  

“Dr. Berg brings a depth of experience in clinical trial design and execution in a wide range of early clinical studies,” said Amy Young, vice president and general manager of DCR. “Her experience augments DCR’s capabilities to manage co-morbid conditions in early clinical trials. She will be responsible for overseeing all clinical aspects of Phase I trials and providing medical monitoring services across study sites.” 

Berg will serve as principal investigator for Phase I-IIa studies being conducted in DCR’s inpatient site. Previously, Berg was director of medical affairs at PRACS Institute, where she was responsible for the planning and development of clinical studies in Phase I through Phase IV with an emphasis on endocrinology and innovator drugs.

“I am excited to join the early clinical research unit at DCR,” said Berg. “I look forward to contributing to their long-standing history of providing operational and scientific excellence.” 

Berg completed her medical degree at the University of Minnesota Medical School in Minneapolis; she fulfilled a family medicine residency training at St. John’s Hospital in St. Paul, Minn., and at the University of Washington in Seattle.  Berg is also a Certified Physician Investigator through the Academy of Pharmaceutical Physicians and Investigators. 

To learn more about DCR and upcoming clinical research trials, visit participateDaVita.com or DCR on Facebook.

Comments
comments powered by Disqus